Aegis Life

About:

Aegis Life works to protect human health from infectious diseases through fusogenix technology.

Top Investors: Bill & Melinda Gates Foundation, Propel(X), Althea Ventures, Strategic Investment Fund

Description:

Aegis Life is a biotechnology company. Their nucleic acid delivery technology,fusogenix PLV, stems from over two decades of research and development in gene delivery. They accelerate the discovery, clinical development, and manufacture of vaccines and therapeutics for infectious diseases.

Total Funding Amount:

$4.45M

Headquarters Location:

San Diego, California, United States

Founded Date:

2020-01-01

Founders:

John Lewis, Matthew Scholz

Number of Employees:

11-50

Last Funding Date:

2024-03-19

IPO Status:

Private

Industries: